Jiawei Chen Selected Research

Anti-Bacterial Agents (Antibiotics)

12/2021	Prevalence, Risk Factors, and Molecular Epidemiology of Intestinal Carbapenem-Resistant Pseudomonas aeruginosa.
10/2008	Characterization of structural variations in the peptidoglycan of vancomycin-susceptible Enterococcus faecium: understanding glycopeptide-antibiotic binding sites using mass spectrometry.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jiawei Chen Research Topics

Disease

63	Neoplasms (Cancer) 02/2024 - 04/2008
18	Inflammation (Inflammations) 01/2024 - 06/2006
16	Neoplasm Metastasis (Metastasis) 05/2024 - 04/2013
16	Atherosclerosis 08/2013 - 07/2003
12	Breast Neoplasms (Breast Cancer) 01/2023 - 01/2015
11	Hypoxia (Hypoxemia) 01/2024 - 10/2011
10	Nasopharyngeal Carcinoma 05/2024 - 01/2020
8	Carcinogenesis 12/2022 - 01/2014
7	Infections 02/2024 - 10/2008
7	Fibrosis (Cirrhosis) 01/2024 - 01/2013
7	Meningioma (Meningiomas) 12/2023 - 01/2021
6	Urinary Bladder Neoplasms (Bladder Cancer) 12/2023 - 01/2018
5	Prostatic Neoplasms (Prostate Cancer) 01/2023 - 07/2011
5	Diabetes Mellitus 01/2023 - 01/2018
5	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2022 - 01/2014
4	Dry Eye Syndromes (Dry Eye Syndrome) 01/2024 - 04/2023
4	Pain (Aches) 01/2024 - 07/2008
4	Dyslipidemias (Dyslipidemia) 10/2023 - 10/2004
4	Renal Cell Carcinoma (Grawitz Tumor) 04/2023 - 01/2012
4	Hepatocellular Carcinoma (Hepatoma) 01/2023 - 10/2014
4	Diabetic Nephropathies (Diabetic Nephropathy) 01/2021 - 04/2012
4	Type 2 Diabetes Mellitus (MODY) 01/2020 - 04/2012
4	Glioma (Gliomas) 12/2019 - 01/2018
4	Uterine Cervical Neoplasms (Cancer of the Cervix) 07/2018 - 04/2011
3	COVID-19 02/2024 - 01/2022
3	Melanoma (Melanoma, Malignant) 01/2024 - 10/2021
3	Pathologic Constriction (Stenosis) 12/2023 - 01/2022
3	Pancreatic Neoplasms (Pancreatic Cancer) 10/2023 - 01/2022
3	Mitochondrial Diseases (Mitochondrial Disease) 01/2023 - 01/2016
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2023 - 07/2021
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2023 - 01/2022
3	Hemorrhage 01/2023 - 01/2021
3	Neuroinflammatory Diseases 01/2022 - 01/2022
3	Hypertension (High Blood Pressure) 01/2022 - 11/2004
3	Malignant Fibrous Histiocytoma 01/2022 - 11/2016
3	Cognitive Dysfunction 01/2022 - 12/2014
3	Hyperglycemia 01/2021 - 02/2012
2	Hypospadias 04/2024 - 01/2021
2	Carcinoma (Carcinomatosis) 12/2023 - 04/2013
2	Colorectal Neoplasms (Colorectal Cancer) 11/2023 - 01/2014
2	Peripheral Nervous System Diseases (PNS Diseases) 01/2023 - 11/2013
2	Cardiotoxicity 01/2023 - 01/2021
2	Thrombosis (Thrombus) 01/2023 - 09/2007
2	Weight Loss (Weight Reduction) 10/2022 - 03/2021
2	Glioblastoma (Glioblastoma Multiforme) 10/2022 - 10/2019
2	Ovarian Neoplasms (Ovarian Cancer) 10/2022 - 04/2011
2	Lung Neoplasms (Lung Cancer) 10/2022 - 01/2018
2	Ototoxicity 06/2022 - 01/2022

Drug/Important Bio-Agent (IBA)

13	Proteins (Proteins, Gene)FDA Link 01/2024 - 01/2013
12	CytokinesIBA 01/2024 - 01/2006
12	Biomarkers (Surrogate Marker)IBA 10/2023 - 11/2013
12	Propofol (Diprivan)FDA LinkGeneric 01/2022 - 02/2012
10	Glucose (Dextrose)FDA LinkGeneric 10/2023 - 01/2018
9	oxidized low density lipoproteinIBA 09/2007 - 07/2003
7	Angiotensin IIIBA 07/2023 - 11/2004
6	RNA (Ribonucleic Acid)IBA 01/2023 - 10/2017
6	CholesterolIBA 01/2022 - 10/2004
6	Messenger RNA (mRNA)IBA 11/2019 - 01/2016
5	Carbapenems (Carbapenem Antibiotics)IBA 01/2023 - 01/2021
5	Cisplatin (Platino)FDA LinkGeneric 12/2022 - 02/2017
5	CollagenIBA 01/2017 - 10/2006
4	Long Noncoding RNAIBA 04/2024 - 01/2017
4	MicroRNAs (MicroRNA)IBA 04/2024 - 01/2018
4	Interleukin-6 (Interleukin 6)IBA 01/2023 - 04/2011
4	Streptozocin (Streptozotocin)FDA Link 01/2021 - 01/2018
3	Peptides (Polypeptides)IBA 01/2024 - 01/2020
3	Carrier Proteins (Binding Protein)IBA 10/2023 - 01/2021
3	AcidsIBA 04/2023 - 01/2022
3	Transcription Factors (Transcription Factor)IBA 01/2023 - 01/2013
3	EnzymesIBA 01/2023 - 10/2017
3	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2023 - 01/2021
3	Retinaldehyde (Retinal)IBA 01/2023 - 01/2018
3	AntioxidantsIBA 10/2022 - 10/2011
3	Matrix Metalloproteinases (MMPs)IBA 01/2022 - 10/2004
3	Oxygen (Dioxygen)IBA 05/2021 - 05/2016
3	Interleukin-10 (Interleukin 10)IBA 12/2019 - 09/2006
3	LigandsIBA 12/2019 - 12/2003
3	Insulin (Novolin)FDA Link 01/2018 - 08/2006
3	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2017 - 04/2008
3	SurvivinIBA 07/2013 - 01/2012
3	Inhibitor of Apoptosis ProteinsIBA 07/2013 - 01/2012
2	VaccinesIBA 02/2024 - 01/2019
2	ChemokinesIBA 01/2024 - 12/2019
2	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 10/2023 - 02/2023
2	Progesterone Receptors (Progesterone Receptor)IBA 10/2023 - 01/2023
2	Interleukin-17 (Interleukin 17)IBA 03/2023 - 12/2019
2	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 03/2013
2	Small Cytoplasmic RNAIBA 01/2023 - 01/2023
2	ProdrugsIBA 12/2022 - 01/2020
2	Small Interfering RNA (siRNA)IBA 09/2022 - 04/2011

Therapy/Procedure

26	Therapeutics 01/2024 - 01/2014
10	Radiotherapy 02/2023 - 10/2017
7	Immunotherapy 02/2024 - 01/2022
7	Drug Therapy (Chemotherapy) 11/2023 - 10/2014
4	Length of Stay 01/2023 - 01/2021
3	Lasers (Laser) 02/2024 - 01/2022
3	Adjuvant Radiotherapy 12/2023 - 01/2021
3	Chemoradiotherapy 11/2023 - 12/2022
3	Anesthesia 01/2022 - 01/2022
2	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 11/2023 - 01/2023